Clinical Trial Update: Once Weekly Infant Corticosteroid Trial for DMD [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating once-weekly corticosteroid therapy in infants with Duchenne Muscular Dystrophy. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• Corticosteroid (corticosteroid)

Snippet

Sponsor: Anne M. Connolly | Conditions: Duchenne Muscular Dystrophy | Phase 4 | Status: RECRUITING